New Palm Beach County location will host grand opening celebration Friday, September 27th TALLAHASSEE, Fla., Sept. 19, 2024 /CNW/ -- Trulieve Cannabis Corp. (CSE: TRUL) (OTCQX: TCNNF) ("Trulieve" or "the Company"), a leading and top-performing cannabis company in the U.S., today announced the opening of a new medical cannabis dispensary in Lake Worth, Florida. A grand opening celebration will... Read more
Rapid success of first program leads to second collaboration to develop optimized enzyme for large scale manufacturing process Enzyme development expected to enable commercial-scale production of the API in 2025 SUNNYVALE, Calif., Sept. 18, 2024 /CNW/ - Willow Biosciences Inc. ("Willow") (TSX: WLLW) (OTCQB: CANSF), a leading biotechnology company focused on revolutionizing industrial... Read more
Yale Child Study Center at the Yale School of Medicine in the USA, Hannover Medical School in Germany and Tel Aviv Sourasky Medical Center in Israel will take part in the trial TEL AVIV, Israel, Sept. 18, 2024 (GLOBE NEWSWIRE) -- SciSparc Ltd. (Nasdaq: SPRC) ("Company" or "SciSparc"), a specialty clinical-stage pharmaceutical company focusing on the development of therapies to treat disorders and rare diseases... Read more
Fort Lauderdale, Florida--(Newsfile Corp. - September 18, 2024) - Flora Growth Corp. (NASDAQ: FLGC) (FSE: 7301) ("Flora" or the "Company") is pleased to announce a strategic supply agreement with Blossom Genetics to bring Colombian medical cannabis to the German market. This partnership will introduce two high sought-after exotic strains, Chemmy Jones and Northern Lights, to Germany, supporting Flora's mission to... Read more
LISBON, Portugal, Sept. 09, 2024 (GLOBE NEWSWIRE) -- Tilray Medical, a division of Tilray Brands, Inc. (“Tilray”) (Nasdaq: TLRY; TSX: TLRY) and a global leader in medical cannabis, empowering the therapeutic alliance between patients and healthcare practitioners to make informed individualized health decisions, today announced a new scientific publication supported by Tilray Medical titled, Treatment in Pain... Read more
New Pinellas County location will host grand opening celebration Friday, September 13th TALLAHASSEE, Fla., Sept. 6, 2024 /CNW/ -- Trulieve Cannabis Corp. (CSE: TRUL) (OTCQX: TCNNF) ("Trulieve" or "the Company"), a leading and top-performing cannabis company in the U.S., announced the opening of a new medical cannabis dispensary in Clearwater, Florida on Saturday, September 7. A grand opening... Read more
HERZLIYA, Israel and CALGARY, Alberta, Sept. 3, 2024 /CNW/ -- Innocan Pharma Corporation (CSE: INNO) (FSE: IP4) (OTCQB: INNPF) ("Innocan" or the "Company"), a pioneer in the pharmaceutical and biotechnology industries, is pleased to announce that it has received a positive response from the U.S. Food and Drug Administration (FDA) following Innocan's successful pre-Investigational New Drug (pre-IND) Type B meeting... Read more
Grand opening celebrations at all four locations Friday, September 6th TALLAHASSEE, Fla., Aug. 30, 2024 /CNW/ -- Trulieve Cannabis Corp. (CSE: TRUL) (OTCQX: TCNNF) ("Trulieve" or "the Company"), a leading and top-performing cannabis company in the U.S., announced the opening of new medical cannabis dispensaries in Miramar Beach, Niceville, and Tampa today and Cocoa on Saturday. Grand opening... Read more
Q2 2024 Revenue Increased 119% Year-over-Year to Over $6.0 Million, Exceeding Management Guidance Management Expects Third Quarter 2024 Revenues of at Least $6.5 Million, with a Gross Profit Margin of 52%+ Vancouver, British Columbia and Rehovot, Israel--(Newsfile Corp. - August 29, 2024) - BioHarvest Sciences Inc. (CSE: BHSC) (OTCQB: CNVCF) ("BioHarvest" or the "Company"), a company pioneering its... Read more
SciSparc would be entitled to receive consideration valued at $3 million in Polyrizon securities, as well as potential milestone fees of approximately $3 million in cash TEL AVIV, Israel, Aug. 28, 2024 (GLOBE NEWSWIRE) -- SciSparc Ltd. (Nasdaq: SPRC) ("Company" or "SciSparc"), a specialty clinical-stage pharmaceutical company focusing on the development of therapies to treat disorders and rare diseases of the... Read more
Designed to elevate focus, mood, energy, and metabolism with clinically proven wellness ingredients Available in three variations - Clarity, Peace, and ReShape SAN DIEGO, Aug. 27, 2024 /PRNewswire/ -- CV Sciences, Inc. (OTCQB: CVSI) (the "Company", "CV Sciences", "our", "us" or "we"), a preeminent consumer wellness company specializing in hemp extracts and other proven, science-backed natural... Read more
SciSparc to conduct the trial at the Yale Child Study Center at the Yale School of Medicine in the USA, Hannover Medical School in Germany and Tel Aviv Sourasky Medical Center in Israel TEL AVIV, Israel, Aug. 23, 2024 (GLOBE NEWSWIRE) -- SciSparc Ltd. (Nasdaq: SPRC) ("Company" or "SciSparc"), a specialty clinical-stage pharmaceutical company focusing on the development of therapies to treat disorders and... Read more
Innocan Pharma Announces Private Placement HERZLIYA, Israel and CALGARY, Alberta, Aug. 22, 2024 /CNW/ -- Innocan Pharma Corporation (CSE: INNO) (FSE: IP4) (OTCQB: INNPF) ("Innocan" or the "Company"), a pioneer in the pharmaceutical and biotechnology industries, is pleased to announce that its subsidiary, BI Sky Global (BI), successfully completed the registration of all its products under the FDA's... Read more
Q2 Revenue up 12% YoY to a record $27.3 Million 11th Consecutive Quarter of Positive Cash Flow from Operations TAMPA, Fla., Aug. 22, 2024 /CNW/ - Cansortium Inc. (CSE: TIUM.U) (OTCQB: CNTMF) ("Cansortium" or the "Company"), a vertically-integrated, multi-state cannabis company operating under the FLUENT™ brand, today announced financial and operating results for the quarter ended June 30,... Read more
MIAMI, Aug. 19, 2024 (GLOBE NEWSWIRE) -- AYR Cannabis Dispensary, a cannabis retail chain owned by AYR Wellness Inc. (CSE: AYR.A, OTCQX: AYRWF) (“AYR” or the “Company”), a leading vertically integrated U.S. multi-state cannabis operator (“MSO”), today announced the opening of AYR Cannabis Manchester, the Company’s first retail location in Connecticut and 94th nationwide. Located at 185 Spencer St, Manchester, CT... Read more
The clinical trial for SCI-210 is conducted in Israel, after which the Company aims to move forward with the commercialization process of SCI-210, first in the Israeli market TEL AVIV, Israel, Aug. 19, 2024 (GLOBE NEWSWIRE) -- SciSparc Ltd. (Nasdaq: SPRC) ("Company" or "SciSparc"), a specialty clinical-stage pharmaceutical company focusing on the development of therapies to treat disorders of the central... Read more
New Pasco County location will host grand opening celebration Friday, August 16th TALLAHASSEE, Fla., Aug. 15, 2024 /CNW/ -- Trulieve Cannabis Corp. (CSE: TRUL) (OTCQX: TCNNF) ("Trulieve" or "the Company"), a leading and top-performing cannabis company in the U.S., today announced the opening of a new medical cannabis dispensary in New Port Richey, Florida. A grand opening celebration will be held... Read more
TORONTO, Aug. 14, 2024 /CNW/ - MediPharm Labs Corp. (TSX: LABS) (OTCQB: MEDIF) (FSE: MLZ) ("MediPharm", "MediPharm Labs" or the "Company") a pharmaceutical company specialized in precision-based cannabinoids announced its financial results for the three and six months ended June 30, 2024 ("Q2 2024"). Key Highlights Adjusted EBITDA(1): Negative $124K in Q2 2024, significantly improved from negative $949K during... Read more
SAN DIEGO, Aug. 13, 2024 /PRNewswire/ -- CV Sciences, Inc. (OTCQB:CVSI) (the "Company", "CV Sciences", "our", "us" or "we"), a preeminent consumer wellness company specializing in hemp extracts and other proven science-backed, natural ingredients and products, today announced its financial results for the quarter ended June 30, 2024. Second Quarter 2024 and Recent Financial and Operating Highlights Generated... Read more
Delivered Q2 2024 revenue of $8.7 million Reported net loss of $1.3 million and adjusted EBITDA1 of $0.5 million SEATTLE / Aug 08, 2024 / Business Wire / Leafly Holdings, Inc. (“Leafly” or “the Company”) (NASDAQ: LFLY), a leading online cannabis discovery marketplace and resource for cannabis consumers, today announced financial results for its second quarter ended June 30, 2024. “We remain focused on... Read more
Collaboration will initially see launch of a new CBD lozenge from Cogent International, a Vectura Fertin Pharma subsidiary, on Aurora's Canadian medical cannabis patient platform Following successful launch of CBD lozenge, the collaboration will explore the potential to launch Vectura Fertin Pharma's future medical cannabis portfolio in Canada EDMONTON, AB, and STAMFORD, Conn., Aug. 1, 2024 /CNW/ -... Read more
New Marion County location will host grand opening celebration Friday, August 2nd TALLAHASSEE, Fla., July 29, 2024 /CNW/ -- Trulieve Cannabis Corp. (CSE: TRUL) (OTCQX: TCNNF) ("Trulieve" or "the Company"), a leading and top-performing cannabis company in the U.S., today announced the opening of a new medical cannabis dispensary in Ocala, Florida. A grand opening celebration will be held Friday,... Read more
NEUMÜNSTER, Germany, July 29, 2024 (GLOBE NEWSWIRE) -- Tilray Brands, Inc. (“Tilray”) (Nasdaq: TLRY; TSX: TLRY), a global leader in medical cannabis research, cultivation, production, and distribution, today announced that Aphria RX GmbH (“Aphria RX”) has received a trading license, which will allow it to sell and distribute a broad range of medical cannabis products to pharmacies, hospitals, and medical... Read more
HERZLIYA, Israel and CALGARY, AB, July 26, 2024 /CNW/ -- Innocan Pharma Corporation (CSE: INNO) (FSE: IP4) (OTCQB: INNPF) ("Innocan" or the "Company"), a pioneer in the pharmaceutical and biotechnology industries, is pleased to announce that the FDA's Center for Veterinary Medicine (CVM) has granted the Company a sponsor fee waiver and assigned an Investigational New Animal Drug (INAD) number for its LPT-CBD... Read more
CANTANHEDE, Portugal, July 24, 2024 (GLOBE NEWSWIRE) -- Tilray Brands, Inc. (“Tilray”) (Nasdaq: TLRY; TSX: TLRY), a global leader in cannabis research, cultivation, production, and distribution, today announced another milestone achievement in medical cannabis in Europe. Following the successful approval of Tilray Medical whole flower THC 18, and approval for the first cannabis extract in Portugal earlier this... Read more
The discovery was demonstrated by utilizing genetic manipulations and 3D spheroid systems, mimicking the main features of human solid tumors TEL AVIV, Israel, July 22, 2024 (GLOBE NEWSWIRE) -- SciSparc Ltd. (Nasdaq: SPRC) (the "Company" or "SciSparc"), a specialty clinical-stage pharmaceutical company focusing on the development of therapies to treat disorders of the central nervous system, announced that... Read more
SciSparc will receive additional payments and execution fees if certain milestones are met TEL AVIV, Israel, July 17, 2024 (GLOBE NEWSWIRE) -- SciSparc Ltd. (Nasdaq: SPRC) ("Company" or "SciSparc"), a specialty clinical-stage pharmaceutical company focusing on the development of therapies to treat disorders and rare diseases of the central nervous system, announced that it has signed a non-binding letter of... Read more
TEL AVIV, Israel, July 16, 2024 (GLOBE NEWSWIRE) -- SciSparc Ltd. (Nasdaq: SPRC) ("Company" or "SciSparc"), a specialty clinical-stage pharmaceutical company focusing on the development of therapies to treat disorders and rare diseases of the central nervous system, announced that an additional patent application with the United States Patent and Trademark Office (“USPTO”) was submitted as part of its ongoing... Read more
New dispensary expands patient access to medical marijuana with ribbon cutting and pop-up event TALLAHASSEE, Fla., July 11, 2024 /CNW/ -- Trulieve Cannabis Corp. (CSE: TRUL) (OTCQX: TCNNF) ("Trulieve" or "the Company"), a leading and top-performing marijuana company in the U.S., today announced the opening of a new Trulieve-affiliated medical marijuana dispensary in Wilkes-Barre, Pennsylvania. The... Read more
New Citrus County location will host grand opening celebration on Friday, July 5th TALLAHASSEE, Fla., July 2, 2024 /CNW/ -- Trulieve Cannabis Corp. (CSE: TRUL) (OTCQX: TCNNF) ("Trulieve" or "the Company"), a leading and top-performing cannabis company in the U.S., today announced the opening of a new medical cannabis dispensary in Homosassa, Florida. A grand opening celebration will be held this... Read more
HERZLIYA, Israel and CALGARY, Alberta , July 2, 2024 /CNW/ -- Innocan Pharma Corporation (CSE: INNO) (FSE: IP4) (OTCQB: INNPF) ("Innocan" or the "Company"), a pioneer in the pharmaceutical and biotechnology industries, is pleased to announce that it has engaged Past-President of the Eastern Pain Association, Dr. William K. Schmidt, to support its LPT-CBD submission process to the FDA for chronic pain. "We are... Read more
VANCOUVER, BC / ACCESSWIRE / July 2, 2024 / 1933 Industries Inc. (the "Company" or "1933 Industries") (CSE:TGIF) (OTCQB:TGIFF), a Nevada-focused cannabis cultivator and producer, is pleased to announce its unaudited interim consolidated financial statements for the three and nine months ended April 30, 2024 and 2023 ("Q3 2024"). All amounts expressed are in Canadian dollars. The Company owns 91% of Alternative... Read more
Grand opening celebrations at both locations Friday, July 5th TALLAHASSEE, Fla., July 1, 2024 /CNW/ -- Trulieve Cannabis Corp. (CSE: TRUL) (OTCQX: TCNNF) ("Trulieve" or "the Company"), a leading and top-performing cannabis company in the U.S., today announced the opening of new medical cannabis dispensaries in Madison and Panama City, Florida. Grand opening celebrations will be held at both... Read more
NEW YORK and SYDNEY, June 20, 2024 (GLOBE NEWSWIRE) -- Tilray Medical, a division of Tilray Brands, Inc. ("Tilray Brands") (NASDAQ: TLRY and TSX: TLRY) and a global leader in medical cannabis, empowering the therapeutic alliance between patients and healthcare practitioners to make informed individualized health decisions, thereby transforming healthcare, today announced the launch of Broken Coast EU-GMP... Read more
MediPharm has licenced global manufacturing, distribution, and sales rights of the novel advanced medical cannabis technology from Remidose Aerosols. Products include metered dose inhalers and aerosol sublingual sprays. MediPharm will assume existing Remidose sales allowing for immediate revenue opportunity. Transaction is non-dilutive, with 100% performance-based payment through a royalty... Read more
HERZLIYA, Israel and CALGARY, AB, June 11, 2024 /CNW/ -- Innocan Pharma Corporation (CSE: INNO) (FSE: IP4) (OTCQB: INNPF) ("Innocan" or the "Company"), a pioneer in the pharmaceutical and biotechnology industries, is pleased to announce the success and conclusion of a preliminary safety evaluation of Innocan's single injection and sustained-release LPT-CBD conducted on minipigs. The animals demonstrated excellent... Read more
Collaboration provides Laurus access to Willow's AI-driven bioengineering platform The strategic alliance includes an initial seven high-value advanced intermediates and active pharmaceutical ingredients, including Willow's corticosteroid programs The agreement with Laurus is the largest collaboration agreement Willow has signed to date SUNNYVALE, Calif., May 30, 2024 /CNW/ - Willow Biosciences... Read more
Combined Company’s footprint will provide access to Florida, New York, Texas, and Pennsylvania, with significant growth potential and future regulatory catalysts in all four states Combined Company expected to leverage Cansortium’s robust operating expertise as well as RIV Capital’s ~US$66 million1,2 cash balance, strengthening both its operating and financial position Transaction has the support of... Read more
Q1 2024 Revenue Increased 147% Year-over-Year to US$5.34 Million Exceeding Previous Guidance Management Expects Q2 2024 Revenue in the Range of US$5.7-6.0 Million Vancouver, British Columbia and Rehovot, Israel--(Newsfile Corp. - May 30, 2024) - BioHarvest Sciences Inc. (CSE: BHSC) (OTCQB: CNVCF)("BioHarvest" or the "Company"), a company pioneering its patented Botanical Synthesis technology platform,... Read more
Q1 Revenue up 14% YoY to $25.2 Million 10th Consecutive Quarter of Positive Cash Flow from Operations TAMPA, Fla., May 30, 2024 (GLOBE NEWSWIRE) -- Cansortium Inc. (CSE: TIUM.U) (OTCQB: CNTMF) (“Cansortium” or the “Company”), a vertically-integrated, multi-state cannabis company operating under the FLUENT™ brand, today announced financial and operating results for the first quarter ended March 31, 2024.... Read more
COPYRIGHT ©2022 GREEN STOCK NEWS